APP下载

CT导向下碘125粒子植入治疗中晚恶性肿瘤的临床分析

2018-10-31潘平生胡金花陈丽萍

中外医疗 2018年15期

潘平生 胡金花 陈丽萍

[摘要] 目的 通过临床实践探讨碘125放射性粒子植入治疗中晚期恶性肿瘤的可行性、安全性及近期疗效。方法 方便选取2013年8月—2015年12月间51例肿瘤患者通过在CT引导下,采用治疗计划系统(TPS)模拟布源,将碘125植入肿瘤病灶内。治疗后定期复查CT评价治疗效果及不良反应。结果 51例肿瘤患者中,完全缓解2例,部分缓解39例,無缓解6例,进展4例,无明显血液学、肝肾功能毒性,无明显放射副作用,植入前后生活质量无明显影响。结论 碘125放射性粒子植入治疗中晚期恶性肿瘤具有较好的近期疗效和较高的肿瘤局部控制率,在提高癌症晚期患者生活质量、减轻局部症状 方面有着明显的优势,是一种安全有效的姑息治疗方法,具有较好的临床价值。

[关键词] 恶性肿瘤;碘125粒子;植入治疗

[中图分类号] R4 [文献标识码] A [文章编号] 1674-0742(2018)05(c)-0182-04

[Abstract] Objective Through clinical practice, the feasibility, safety and short-term efficacy of iodine 125 radioactive seeds implanted in the treatment of advanced malignant tumors were investigated. Methods From August 2013 to December 2015 In 51 cases of cancer patients, iodine 125 was implanted in the tumor foci by CT-guided treatment planning system (TPS). After treatment, CT was regularly reviewed to evaluate the treatment effect and adverse reactions. Results Of 51 patients with cancer, 2 case had complete remission, 39 case had partial remission, 6 case had no remission, and 4 case had progress. No hematologic, hepatic or renal toxicity was observed, no radiological side effects were observed, and there was no significant effect on quality of life before and after implantation. Conclusion Iodine-125 radioactive seeds implanted in the treatment of advanced malignant tumors have good short-term efficacy and high local control rate of tumors. It has obvious advantages in improving the quality of life of patients with advanced cancer and reducing the local symptoms. It is a safe and effective palliative, with good clinical value.

[Key words] Malignant tumors; 125Iseeds; Implantation therapy

放射性粒子植入近距离治疗肿瘤虽已有百年历史,因无相关的配套设施保证精确的定位,限制了它的使用。但随着放射治疗的三维计划系统和CT、超声引导下精确定位系统的出现,在近10余年,粒子植入治疗肿瘤呈快速发展。目前,国外已将碘125粒子永久性植入作为治疗前列腺癌等恶性肿瘤的首选方法[1],恶性肿瘤已成为威胁人们健康的三大疾病之一,而且多数患者确诊时多为中晚期,手术治愈率<40%,术后肿瘤的复发和转移率也高。常规放化疗等综合治疗中晚期恶性肿瘤的效果仍不理想。该院肿瘤中心于2013年8月—2015年12月在CT引导下完成了51例恶性肿瘤的粒子植入治疗,现报道如下。……

登录APP查看全文